News › Politics
FDA orders new warnings for GLP-1 drugs over rare vision-loss risk
First reported Nov 9, 9:53 AM ET · 18 articles from 16 outlets
Who covered it
4 of the 32 left-leaning outlets we read (13%) · 7 of 31 center (23%) · 4 of 31 right-leaning (13%) · plus 1 not rated
Who reported it first
Nov 9, 9:53 AM ETCenter
Nov 9, 11:43 AM ETCenter
Nov 9, 2:22 PM ETRight
Nov 9, 4:07 PM ETCenter
Nov 9, 4:34 PM ETLeft
Coverage
Left · 4
FDA warns GLP-1 drugs carry potential risk of rare eye condition
FDA Adds Rare Vision-loss Warning To Popular GLP-1 Drugs
FDA adds rare vision-loss warning to popular GLP-1 drugs
FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications
Center · 8
US FDA Orders New Eye Risk Warnings for Ozempic, Zepbound
US FDA orders new eye risk warnings for Ozempic, Zepbound
FDA adds rare vision-loss warning to popular GLP-1 drugs
FDA warns of rare vision-loss side effect from GLP-1 drugs
FDA tells GLP-1 makers to warn of potential vision loss side effect
FDA adds rare vision-loss warning to popular GLP-1 drugs
FDA orders GLP-1 vision loss warning for Ozempic, Zepbound
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
Right · 4
FDA Orders New Eye Risk Warnings for GLP-1s
FDA Now Requiring GLP-1 Makers to Warn About Rare but Severe Eye Condition
FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
FDA warning: Ozempic, other weight-loss drugs can cause vision loss
Headlines link to each outlet's own article. Lean is from published research on each outlet's audience (Robertson et al., 2018), not our judgment of its content. Stories are grouped automatically from 100 outlets' public feeds. Method